Potentiating effect of the flavonolignan (-)-hydnocarpin in combination with vincristine in a sensitive and P-gp-expressing acute lymphoblastic leukemia cell line

Phytotherapy Research

Volumn 27, Issue 11, 2013, Pages 1735-1738

  Bueno Pérez, Lynette ^a   Pan, Li ^a   Sass, Ellen ^a   Gupta, Sneha V ^a   Lehman, Amy ^a   Kinghorn, A Douglas ^a   Lucas, David M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

( ) hydnocarpin; multidrug resistance; P glycoprotein; vincristine

Indexed keywords

FLAVONOLIGNAN; HYDNOCARPIN; MULTIDRUG RESISTANCE PROTEIN; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER INHIBITION; COMBINATION CHEMOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL; MONOTHERAPY; PROTEIN EXPRESSION;

(-)-HYDNOCARPIN; MULTIDRUG RESISTANCE; P-GLYCOPROTEIN; VINCRISTINE;

CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FLAVONOLIGNANS; HUMANS; P-GLYCOPROTEIN; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; VINCRISTINE;

EID: 84886287275     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4903     Document Type: Article

References (24)

1. Afifi MSA, Ahmed MM, Pezzuto JM, Kinghorn AD,. 1993. Cytotoxic flavonolignans and flavones from Verbascum sinaiticum leaves. Phytochemistry 34: 839-841.
2. Alvarez AI, Real R, Pérez M, Mendoza G, Prieto JG, Merino G,. 2010. Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response. J Pharm Sci 99: 598-617.
3. Chan K-F, Wong ILK, Kan JWY, Yan CSW, Chow LMC, Chan TH,. 2012. Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: structure-activity relationship and mechanism of modulation. J Med Chem 55: 1999-2014.
4. Chin Y-W, Jones WP, Waybright TJ, et al,. 2006. Tropane aromatic ester alkaloids from a large-scale re-collection of Erythroxylum pervilleii stem bark obtained in Madagascar. J Nat Prod 69: 414-417.
5. Crowley E, McDevitt CA, Callaghan R,. 2010. Generating inhibitors of P-glycoprotein: where to, now? Methods Mol Biol 596: 405-432.
6. Duarte N, Gyemant N, Abreu PM, Molnar J, Ferreira M-JU,. 2006. New macrocyclic lathyrane diterpenes, from Euphorbia lagascae, as inhibitors of multidrug resistance of tumour cells. Planta Med 72: 162-168.
7. Duarte N, Varga A, Cherepnev G, Radics R, Molnar J, Ferreira M-JU,. 2007. Apoptosis induction and modulation of P-glycoprotein mediated multidrug resistance by new macrocyclic lathyrane-type diterpenoids. Bioorg Med Chem 15: 546-554.
8. Gupta SV, Sass EJ, Davis ME, et al,. 2011. Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cells. AAPS J 13: 357-364.
9. Guz NR, Stermitz FR,. 2000. Synthesis and structures of regioisomeric hydnocarpin-type flavonolignans. J Nat Prod 63: 1140-1145.
10. Krishna R, Mayer LD,. 2000. Multidrug resistance (MDR) in cancer. mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 11: 265-283.
11. Longley DB, Johnston PG,. 2005. Molecular mechanisms of drug resistance. J Pathol 205: 275-292.
12. Mi Q, Cui B, Silva GL, et al,. 2001. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype. Cancer Res 61: 4030-4037.
13. Molnár J, Engi H, Hohmann J, et al,. 2010. Reversal of multidrug resistance by natural substances from plants. Curr Top Med Chem 10: 1757-1768.
14. Neyfakh AA,. 1988. Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp Cell Res 174: 168-176.
15. Nobili S, Landini I, Mazzei T, Mini E,. 2011. Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression. Med Res Rev doi: 10.1002/med.20239
16. Ozben T,. 2006. Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett 580: 2903-2909.
17. Pan L, Chin Y-W, Chai H-B, Ninh TN, Soejarto DD, Kinghorn AD,. 2009. Bioactivity-guided isolation of cytotoxic constituents of Brucea javanica collected in Vietnam. Bioorg Med Chem 17: 2219-2224.
18. Pan L, Kardono LBS, Riswan S, et al,. 2010. Isolation and characterization of minor analogues of silvestrol and other constituents from a large-scale re- collection of Aglaia foveolata. J Nat Prod 73: 1873-1878.
19. Ramalhete C, Molnar J, Mulhovo S, Rosario VE, Ferreira M-JU,. 2009. New potent P-glycoprotein modulators with the cucurbitane scaffold and their synergistic interaction with doxorubicin on resistant cancer cells. Bioorg Med Chem 17: 6942-6951.
20. Reddy SV, Tiwari AK, Kumar US, Rao RJ, Rao JM,. 2005. Free radical scavenging, enzyme inhibitory constituents from antidiabetic ayurvedic medicinal plant Hydnocarpus wightiana Blume. Phytother Res 19: 277-281.
21. Sharma DK, Hall IH,. 1991. Hypolipidemic, anti-inflammatory, and antineoplastic activity and cytotoxicity of flavonolignans isolated from Hydnocarpus wightiana seeds. J Nat Prod 54: 1298-1302.
22. Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K,. 2000. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci USA 97: 1433-1437.
23. Stermitz FR, Beeson TD, Mueller PJ, Hsiang JF, Lewis K,. 2001. Staphylococcus aureus MDR efflux pump inhibitors from a Berberis and a Mahonia (sensu strictu) species. Biochem Syst Ecol 29: 793-798.
24. Sun L-r, Cui S-x, Qu X-j,. 2009. Overcoming multidrug resistance in cancer: an update on research of natural products. Drugs Future 34: 53-59.